Contact Us
Full resource library

Alloy Therapeutics resources all in one place

Modality
Solution
Type
Modality
Solution
Type
  • Press Releases
Alloy Therapeutics Enters Into Agreement to Advance Novel Antibody Discovery Platform
Learn more
Cyclic oligonucleotides
  • Perspectives
Rethinking Antisense Architecture with Transient Cyclic Oligonucleotides for Next-Generation RNA Therapeutics
Learn more
AI/ML in antibody discovery
  • Technical Notes
AI/ML in Antibody Discovery: What Works, What Doesn’t, What’s Next
Learn more
Integrating AI/ML
  • Webinars
From Data to Decisions in Antibody Discovery: Integrating AI/ML
Learn more
antibody discovery for complex fibrosis targets
  • Press Releases
Alloy Accelerates Mediar Timeline to the Clinic for Complex Fibrosis Targets
Learn more
de-risking antibody discovery
  • Technical Notes
Accelerated Antibody Discovery for Complex Fibrosis Targets
Learn more
Tahoe Therapeutics joint venture
  • Press Releases
Tahoe Therapeutics and Alloy Therapeutics to Form Joint Venture and Develop First-in-Class Antibody-Drug Conjugates for Hard-to-Treat Cancers
Learn more
antibody discovery for complex fibrosis targets
  • Press Releases
Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology
Learn more
Cryo-Electron Microscopy
  • Press Releases
Alloy Therapeutics Appoints Christian Cobaugh, Ph.D., as CEO of Alloy Genetic Medicines
Learn more